Drug Trial Radar · NCT00057343
Safety and Efficacy of Zevalin in the Treatment of Non-Hodgkin's Lymphoma
Last checked: Nov 20, 2026Latest source record: Sep 12, 2006 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
400
Actual
Start
Mar 2003
Primary completion
Not stated
Sponsor
- Lead sponsor
- BiogenBiogen (BIIB)
- Sponsor type
- Industry
- First posted
- Apr 1, 2003
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to provide treatment for patients who have relapsed NHL or refractory NHL, and to determine the effectiveness and safety of the Zevalin and Rituxan regimens or Rituxan therapy alone on your disease.
Conditions
- Non-Hodgkin's Lymphoma
Interventions
Zevalin (ibritumomab tiuxetan)Drug
Rituxan (rituximab)Drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Event-free survival
Locations
67 sites in 1 country. Site status is shown where the registry gives one.
Research Site
Huntsville, Alabama
Research Site
Scottsdale, Arizona
Research Site
Little Rock, Arkansas
Research Site
Bakersfield, California
Research Site
Concord, California
Research Site
Duarte, California
Research Site
Loma Linda, California
Research Site
Los Angeles, California
Research Site
Mission Viejo, California
Research Site
Newport Beach, California
Research Site
Orange, California
Research Site
Sacramento, California
Biogen Idec Incorporated
San Diego, California
Research Site
San Diego, California
Research Site
Santa Barbara, California
Research Site
Vallejo, California
Research Site
Farmington, Connecticut
Research Site
Newark, Delaware
Research Site
Jacksonville, Florida
Research Site
Lakeland, Florida
Research Site
Boise, Idaho
Research Site
Coeur d'Alene, Idaho
Research Site
Aurora, Illinois
Research Site
Chicago, Illinois
Research Site
Evanston, Illinois
Research Site
Harvey, Illinois
Research Site
Maywood, Illinois
Research Site
Urbana, Illinois
Research Site
Indianapolis, Indiana
Research Site
Munster, Indiana
Research Site
Kansas City, Kansas
Research Site
Baltimore, Maryland
Research Site
Boston, Massachusetts
Research Site
Ann Arbor, Michigan
Research Site
Detroit, Michigan
Research Site
Flint, Michigan
Research Site
Royal Oak, Michigan
Research Site
Saint Joseph, Michigan
Research Site
Minneapolis, Minnesota
Research Site
Rochester, Minnesota
Showing 40 of 67 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.